---
schema_version: "secwatch.filing_event.v1"
accession: "0000064803-23-000032"
form_type: "8-K"
ticker: "CVS"
cik: "0000064803"
company_name: "CVS HEALTH Corp"
filed_at: "2023-08-02T23:59:59+00:00"
generated_at: "2026-06-12T15:23:19.988604+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# CVS Health Q2 rev +10%, EPS $1.48; lowers GAAP EPS guidance to $6.53-$6.75

## Summary
- Revenue $88.9B, +10.3% YoY; GAAP diluted EPS $1.48 (down from $2.29); adj EPS $2.21 (down from $2.53).
- Full-year GAAP diluted EPS guidance cut to $6.53-$6.75 from $6.90-$7.12; adj EPS guidance confirmed $8.50-$8.70.
- Operating income $3.23B, down $1.44B YoY; adjusted operating income $4.48B down $521M.
- Completed Oak Street Health acquisition on May 2, 2023; returned $795M to shareholders via dividends in Q2.
- Year-to-date cash flow from operations $13.3B; reaffirmed FY cash flow guidance $12.5B-$13.5B.

## SEC filing metadata
- accession: 0000064803-23-000032
- form_type: 8-K
- ticker: CVS
- cik: 0000064803
- company_name: CVS HEALTH Corp
- filed_at: 2023-08-02T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/64803/000006480323000032/0000064803-23-000032-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/64803/000006480323000032/cvs-20230802.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000064803-23-000032
- JSON: https://secwatch.observer/filing/0000064803-23-000032.json
- Plain text: https://secwatch.observer/filing/0000064803-23-000032.txt

## Key facts
- Earnings Releases
  CVS HEALTH Corp reported the three months ended June 30, 2023 results: revenue $88,921, EPS $1.48. Guidance lowered.
  - Period: the three months ended June 30, 2023
  - Revenue: $88,921
  - EPS: $1.48
  - Guidance: lowered
  - Result: reported results
  source text: Adjusted EPS of $4.41 • Generated cash flow from operations of $13.3 billion Three Months Ended June 30, In millions, except per share amounts 2023 2022 Change Total revenues $ 88,921 $ 80,636 $ 8,285 Operating income 3,234 4,669 (1,435) Adjusted operating income (1) 4,481 5,002 (521) Diluted earnings per share $ 1.48 $ 2.29 $ (0.81) Adjusted EPS (2) $ 2.21 $
  evidence_url: https://www.sec.gov/Archives/edgar/data/64803/000006480323000032/0000064803-23-000032-index.htm
- Earnings Releases
  CVS HEALTH Corp reported 2023 Full-year results: EPS $6.53 to $6.75. Guidance lowered.
  - Period: 2023 Full-year
  - EPS: $6.53 to $6.75
  - Guidance: lowered
  - Result: guidance update
  source text: Revised GAAP diluted EPS guidance range to $6.53 to $6.75 from $6.90 to $7.12
  evidence_url: https://www.sec.gov/Archives/edgar/data/64803/000006480323000032/0000064803-23-000032-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.